---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-102338"
form_type: "8-K"
ticker: "CATX"
cik: "0000728387"
company_name: "Perspective Therapeutics, Inc."
filed_at: "2024-08-30T23:59:59+00:00"
generated_at: "2026-05-31T06:53:59.140813+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# CFO Mark Austin departs; separation agreement provides $138K severance and COBRA subsidy

## Summary
- Mark Austin ceased as executive officer and co-principal financial officer on Aug 16, 2024.
- Separation agreement finalized Aug 26, 2024; Austin remains strategic advisor through Aug 30, 2024.
- Severance includes $138,360.75 (6 months base salary) and $7,686.54 for COBRA coverage.
- Payments conditional on signing release and compliance with separation terms.

## SEC filing metadata
- accession: 0000950170-24-102338
- form_type: 8-K
- ticker: CATX
- cik: 0000728387
- company_name: Perspective Therapeutics, Inc.
- filed_at: 2024-08-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/728387/000095017024102338/0000950170-24-102338-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/728387/000095017024102338/catx-20240826.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-102338
- JSON: https://secwatch.observer/filing/0000950170-24-102338.json
- Plain text: https://secwatch.observer/filing/0000950170-24-102338.txt

## Key facts
- Executive change
  Mark Austin departed as co-principal financial officer and principal accounting officer at Perspective Therapeutics, Inc..
  - Action: ceased serving as executive officer and co-principal financial officer
  - Role: co-principal financial officer and principal accounting officer
  source text: Mark Austin ceased serving as an executive officer of the Company and as the Company's “co-principal financial officer” and “principal accounting officer” on August 16, 2024.
  evidence_url: https://www.sec.gov/Archives/edgar/data/728387/000095017024102338/0000950170-24-102338-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.